SEC Company Response from Minerva Neurosciences, Inc. (NERV) (CIK 0001598646) (NERV) — Jun 30, 2014
Minerva Neurosciences, Inc. (NERV) (CIK 0001598646)
Date: June 30, 2014 · CIK: 0001598646 · Accession: 0001104659-14-049243
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-195169
Letter
Minerva Neurosciences
245 First Street
Suite 1800
Cambridge, MA 02142
June 30, 2014
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Attention:
Jeffrey Riedler
Assistant Director
Re: Minerva Neurosciences, Inc. (the “Company”)
Registration Statement on Form S-1
File No. 333-195169
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:00 pm, Washington, D.C. time on June 30, 2014, or as soon thereafter as is practicable, or at such later time as the Company may orally request via telephone call to the staff. The Registrant hereby authorizes David W. Pollak, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Morgan, Lewis & Bockius LLP, by calling David W. Pollak at (212) 309-6058.
The Company hereby acknowledges that:
· should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
· the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
· the Company may not assert staff comments and the declaration of effectiveness as a defence in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Very truly yours,
Minerva Neurosciences, Inc.
Show Raw Text
CORRESP 1 filename1.htm Minerva Neurosciences 245 First Street Suite 1800 Cambridge, MA 02142 June 30, 2014 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549 Attention: Jeffrey Riedler Assistant Director Re: Minerva Neurosciences, Inc. (the “Company”) Registration Statement on Form S-1 File No. 333-195169 Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:00 pm, Washington, D.C. time on June 30, 2014, or as soon thereafter as is practicable, or at such later time as the Company may orally request via telephone call to the staff. The Registrant hereby authorizes David W. Pollak, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Morgan, Lewis & Bockius LLP, by calling David W. Pollak at (212) 309-6058. The Company hereby acknowledges that: · should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; · the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and · the Company may not assert staff comments and the declaration of effectiveness as a defence in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Very truly yours, Minerva Neurosciences, Inc. By: /s/ Rogerio Vivaldi Coelho Name: Rogerio Vivaldi Coelho Title: Chief Executive Officer cc: Morgan, Lewis & Bockius LLP 2